Annual Statements Open main menu

OWENS & MINOR INC/VA/ - Quarter Report: 2015 June (Form 10-Q)

Table of Contents

 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________________ 
FORM 10-Q
________________________________________________ 
 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2015
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission file number 1-9810
_______________________________________________________
Owens & Minor, Inc.
(Exact name of Registrant as specified in its charter)
_______________________________________________________
Virginia
54-1701843
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
 
 
9120 Lockwood Boulevard,
Mechanicsville, Virginia
23116
(Address of principal executive offices)
(Zip Code)
 
 
Post Office Box 27626,
Richmond, Virginia
23261-7626
(Mailing address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (804) 723-7000
 _________________________________________________________
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “larger accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
x
Accelerated filer
¨
Non-accelerated filer
o  (Do not check if a smaller reporting company)
Smaller reporting company
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x
The number of shares of Owens & Minor, Inc.’s common stock outstanding as of July 24, 2015, was 63,018,058 shares.
 
 
 
 
 



Table of Contents

Owens & Minor, Inc. and Subsidiaries
Index
 
Page
 
 
 
 
 
 
 
 
 
 

2


Table of Contents

Part I. Financial Information
Item 1. Financial Statements
Owens & Minor, Inc. and Subsidiaries
Consolidated Statements of Income
(unaudited)
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(in thousands, except per share data)
2015
 
2014
 
2015
 
2014
Net revenue
$
2,422,167

 
$
2,305,858

 
$
4,813,363

 
$
4,562,239

Cost of goods sold
2,123,830

 
2,023,586

 
4,217,425

 
3,998,771

Gross margin
298,337

 
282,272

 
595,938


563,468

Selling, general and administrative expenses
231,498

 
225,838

 
465,323

 
451,448

Acquisition-related and exit and realignment charges
5,707

 
7,593

 
15,623

 
10,855

Depreciation and amortization
15,460

 
13,892

 
31,329

 
27,756

Other operating income, net
(2,188
)
 
(2,152
)
 
(5,172
)
 
(9,978
)
Operating earnings
47,860

 
37,101

 
88,835

 
83,387

Interest expense, net
6,680

 
3,342

 
13,560

 
6,589

Income before income taxes
41,180

 
33,759

 
75,275

 
76,798

Income tax provision
16,954

 
13,883

 
32,109

 
31,436

Net income
$
24,226

 
$
19,876

 
$
43,166

 
$
45,362

Net income per common share:
 
 
 
 
 
 
 
Basic
$
0.39

 
$
0.32

 
$
0.69

 
$
0.72

Diluted
$
0.39

 
$
0.32

 
$
0.69

 
$
0.72

Cash dividends per common share
$
0.2525

 
$
0.25

 
$
0.505

 
$
0.50



See accompanying notes to consolidated financial statements.
3

Table of Contents

Owens & Minor, Inc. and Subsidiaries
Consolidated Statements of Comprehensive Income
(unaudited)
 
 
Three Months Ended    June 30,
 
Six Months Ended    June 30,
(in thousands)
2015
 
2014
 
2015
 
2014
Net income
$
24,226

 
$
19,876

 
$
43,166

 
$
45,362

Other comprehensive income (loss), net of tax:
 
 
 
 
 
 
 
Currency translation adjustments (net of income tax of $0 in 2015 and 2014)
6,606

 
(570
)
 
(21,335
)
 
(103
)
Change in unrecognized net periodic pension costs (net of income tax of $141 and $285 in 2015 and $90 and $186 in 2014)
260

 
112

 
518

 
219

Other (net of income tax of $0 in 2015 and $8 and $16 in 2014)
(8
)
 
15

 
30

 
6

Total other comprehensive income (loss), net of tax
6,858

 
(443
)
 
(20,787
)
 
122

Comprehensive income
$
31,084

 
$
19,433

 
$
22,379

 
$
45,484



See accompanying notes to consolidated financial statements.
4

Table of Contents

Owens & Minor, Inc. and Subsidiaries
Consolidated Balance Sheets
(unaudited)
 
 
June 30,
 
December 31,
(in thousands, except per share data)
2015
 
2014
Assets
 
 
 
Current assets
 
 
 
Cash and cash equivalents
$
200,969

 
$
56,772

Accounts and notes receivable, net of allowances of $13,220 and $13,306
580,739

 
626,192

Merchandise inventories
903,501

 
872,457

Other current assets
275,481

 
315,285

Total current assets
1,960,690

 
1,870,706

Property and equipment, net of accumulated depreciation of $173,278 and $163,377
219,372

 
232,979

Goodwill, net
421,760

 
423,276

Intangible assets, net
100,904

 
108,593

Other assets, net
92,180

 
99,852

Total assets
$
2,794,906

 
$
2,735,406

Liabilities and equity
 
 
 
Current liabilities
 
 
 
Accounts payable
$
753,495

 
$
608,846

Accrued payroll and related liabilities
34,797

 
31,507

Deferred income taxes
41,378

 
37,979

Other accrued liabilities
288,432

 
326,223

Total current liabilities
1,118,102

 
1,004,555

Long-term debt, excluding current portion
574,623

 
608,551

Deferred income taxes
62,282

 
63,901

Other liabilities
62,772

 
67,561

Total liabilities
1,817,779

 
1,744,568

Commitments and contingencies

 

Equity
 
 
 
Owens & Minor, Inc. shareholders’ equity:
 
 
 
Common stock, par value $2 per share; authorized - 200,000 shares; issued and outstanding - 63,018 shares and 63,070 shares
126,036

 
126,140

Paid-in capital
205,727

 
202,934

Retained earnings
690,152

 
685,765

Accumulated other comprehensive income
(44,788
)
 
(24,001
)
Total equity
977,127

 
990,838

Total liabilities and equity
$
2,794,906

 
$
2,735,406



See accompanying notes to consolidated financial statements.
5

Table of Contents

Owens & Minor, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(unaudited)
 
 
Six Months Ended June 30,
(in thousands)
2015
 
2014
Operating activities:
 
 
 
Net income
$
43,166

 
$
45,362

Adjustments to reconcile net income to cash provided by operating activities:
 
 
 
Depreciation and amortization
36,138

 
27,756

Share-based compensation expense
5,048

 
4,190

Provision for losses on accounts and notes receivable
41

 
334

Deferred income tax (benefit) expense
2,992

 
(5,151
)
Changes in operating assets and liabilities:
 
 
 
Accounts and notes receivable
41,622

 
28,477

Merchandise inventories
(31,866
)
 
(48,575
)
Accounts payable
145,682

 
54,922

Net change in other assets and liabilities
2,771

 
(32,765
)
Other, net
1,196

 
(1,078
)
Cash provided by operating activities
246,790

 
73,472

Investing activities:
 
 
 
Additions to property and equipment
(12,009
)
 
(25,657
)
Additions to computer software and intangible assets
(10,816
)
 
(13,166
)
Proceeds from sale of investment

 
1,937

Proceeds from sale of property and equipment
837

 
45

Cash used for investing activities
(21,988
)
 
(36,841
)
Financing activities:
 
 
 
Change in bank overdraft
1,530

 

Repayment of revolving credit facility
(33,700
)
 

Cash dividends paid
(31,867
)
 
(31,564
)
Repurchases of common stock
(7,440
)
 
(9,448
)
Excess tax benefits related to share-based compensation
457

 
444

Proceeds from exercise of stock options

 
1,180

Purchase of noncontrolling interest

 
(1,500
)
Other, net
(5,112
)
 
(4,441
)
Cash used for financing activities
(76,132
)
 
(45,329
)
Effect of exchange rate changes on cash and cash equivalents
(4,473
)
 
(1,180
)
Net increase (decrease) in cash and cash equivalents
144,197

 
(9,878
)
Cash and cash equivalents at beginning of period
56,772

 
101,905

Cash and cash equivalents at end of period
$
200,969

 
$
92,027

Supplemental disclosure of cash flow information:
 
 
 
Income taxes paid, net
$
27,542

 
$
56,837

Interest paid
$
13,260

 
$
7,402



See accompanying notes to consolidated financial statements.
6

Table of Contents

Owens & Minor, Inc. and Subsidiaries
Consolidated Statements of Changes in Equity
(unaudited)
 
 
Owens & Minor, Inc. Shareholders’ Equity
 
 
 
 
(in thousands, except per share data)
Common
Shares
Outstanding
 
Common 
Stock
($ 2 par value )
 
Paid-In
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive Income
(Loss)
 
Noncontrolling
Interest
 
Total
Equity
Balance December 31, 2013
63,096

 
$
126,193

 
$
196,605

 
$
691,547

 
$
9,568

 
$
1,130

 
$
1,025,043

Net income
 
 
 
 
 
 
45,362

 
 
 
 
 
45,362

Other comprehensive income
 
 
 
 
 
 
 
 
122

 
 
 
122

Dividends declared ($0.50 per share)
 
 
 
 
 
 
(31,473
)
 
 
 
 
 
(31,473
)
Shares repurchased and retired
(277
)
 
(555
)
 
 
 
(8,893
)
 
 
 
 
 
(9,448
)
Share-based compensation expense, exercises and other
247

 
495

 
3,109

 
 
 
 
 
 
 
3,604

Purchase of noncontrolling interest
 
 
 
 
(695
)
 
 
 
 
 
(1,130
)
 
(1,825
)
Balance June 30, 2014
63,066

 
$
126,133

 
$
199,019

 
$
696,543

 
$
9,690

 
$

 
$
1,031,385

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance December 31, 2014
63,070

 
$
126,140

 
$
202,934

 
$
685,765

 
$
(24,001
)
 
$

 
$
990,838

Net income
 
 
 
 
 
 
43,166

 
 
 
 
 
43,166

Other comprehensive income
 
 
 
 
 
 
 
 
(20,787
)
 
 
 
(20,787
)
Dividends declared ($0.505 per share)
 
 
 
 
 
 
(31,779
)
 
 
 
 
 
(31,779
)
Shares repurchased and retired
(220
)
 
(440
)
 
 
 
(7,000
)
 
 
 
 
 
(7,440
)
Share-based compensation expense, exercises and other
168

 
336

 
2,793

 
 
 
 
 
 
 
3,129

Balance June 30, 2015
63,018

 
$
126,036

 
$
205,727

 
$
690,152

 
$
(44,788
)
 
$

 
$
977,127



See accompanying notes to consolidated financial statements.
7

Table of Contents

Owens & Minor, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(unaudited)
(in thousands, unless otherwise indicated)
Note 1—Basis of Presentation and Use of Estimates
Basis of Presentation
The accompanying unaudited consolidated financial statements include the accounts of Owens & Minor, Inc. and the subsidiaries it controls (we, us, or our) and contain all adjustments (which are comprised only of normal recurring accruals and use of estimates) necessary to conform with U.S. generally accepted accounting principles (GAAP). All significant intercompany accounts and transactions have been eliminated. The results of operations for interim periods are not necessarily indicative of the results expected for the full year.
Reclassifications
Certain prior year amounts have been reclassified to conform to current year presentation.
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires us to make assumptions and estimates that affect reported amounts and related disclosures. Actual results may differ from these estimates.
Note 2—Fair Value
The carrying amounts of cash and cash equivalents, accounts receivable, financing receivables, accounts payable and financing payables included in the consolidated balance sheets approximate fair value due to the short-term nature of these instruments. The fair value of long-term debt is estimated based on quoted market prices or dealer quotes for the identical liability when traded as an asset in an active market (Level 1) or, if quoted market prices or dealer quotes are not available, on the borrowing rates currently available for loans with similar terms, credit ratings and average remaining maturities (Level 2). We determine the fair value of our derivatives based on quoted market prices. See Note 8 for the fair value of long-term debt and Note 9 for the fair value of derivatives.
Note 3—Acquisitions
On October 1, 2014, we completed the acquisition of Medical Action Industries Inc. (Medical Action), a leading producer of surgical kits and procedure trays, which enabled an expansion of our capabilities in the assembly of kits, packs and trays for the healthcare market.
On November 1, 2014, we acquired ArcRoyal, a privately held surgical kitting company based in Ireland (ArcRoyal). The transaction expanded our capabilities in the assembly of kits, packs and trays in the European healthcare market.
The combined consideration for these two acquisitions was $261.6 million, net of cash acquired, and including debt assumed of $13.4 million (capitalized lease obligations).

The purchase price was allocated to the underlying assets acquired and liabilities assumed based upon our preliminary estimate of their fair values at the date of acquisition, with certain exceptions permitted under GAAP. The combined purchase price exceeded the preliminary estimated fair value of the net tangible and identifiable intangible assets by $151.3 million, which was allocated to goodwill. The following table presents, in the aggregate, the preliminary estimated fair value of the assets acquired and liabilities assumed recognized as of the acquisition date. Adjustments relate to revised estimates pending completion of our valuation. The allocation of purchase price to assets and liabilities acquired is not yet complete as we are working to finalize the valuation of specific fixed assets and liabilities.

8


Table of Contents

 
Preliminary Fair
Value Estimated as of
Acquisition Date
 
Differences Between Prior and Current Period Preliminary Fair Value Estimate
 
Preliminary Fair
Value Currently Estimated as of
Acquisition Date
Assets acquired:
 
 
 
 
 
Current assets
$
90,608

 
$
147

 
$
90,755

Property and equipment
34,048

 
(1,234
)
 
32,814

Goodwill
150,492

 
773

 
151,265

Intangible assets
77,623

 

 
77,623

Total assets
352,771

 
(314
)
 
352,457

Liabilities assumed:
 
 
 
 

Current liabilities
64,736

 
(314
)
 
64,422

Noncurrent liabilities
26,426

 

 
26,426

Total liabilities
91,162

 
(314
)
 
90,848

Fair value of net assets acquired, net of cash
$
261,609

 
$

 
$
261,609

We are amortizing the fair value of acquired intangible assets, primarily customer relationships, over their remaining weighted average useful lives of 14 years.
Goodwill of $151.3 million consists largely of expected opportunities to expand our kitting capabilities. We assigned goodwill of $21.9 million to our International segment and $129.4 million to our Domestic segment. None of the goodwill recognized is expected to be deductible for income tax purposes.
Pro forma results of operations for these acquisitions have not been presented because the effects on revenue and net income were not material to our historic consolidated financial statements.
Acquisition-related expenses in 2015 consisted primarily of transition costs incurred to integrate the acquired operations (including certain severance and contractual payments to former management). We recognized pre-tax acquisition-related expenses of $1.8 million in the second quarter and $4.4 million year-to-date in 2015 related to these activities.
Acquisition-related expenses of $3.5 million and $4.1 million in the three and six months ended June 30, 2014 consisted of costs to perform due diligence and analysis related to the Medical Action and ArcRoyal acquisitions, as well as certain costs in Movianto to resolve issues and claims with the former owner.
Note 4—Financing Receivables and Payables
At June 30, 2015 and December 31, 2014, we had financing receivables of $157.5 million and $196.2 million and related payables of $136.5 million and $168.8 million outstanding under our order-to-cash program and product financing arrangements, which were included in other current assets and other current liabilities, respectively, in the consolidated balance sheets.
Note 5—Goodwill and Intangible Assets
The following table summarizes the changes in the carrying amount of goodwill through June 30, 2015:
 
Domestic
Segment
 
International
Segment
 
Total
Carrying amount of goodwill, December 31, 2014
$
377,089

 
$
46,187

 
$
423,276

Currency translation adjustments

 
(2,289
)
 
(2,289
)
Acquisitions (see Note 3)
773

 

 
773

Carrying amount of goodwill, June 30, 2015
$
377,862

 
$
43,898

 
$
421,760


9


Table of Contents

Intangible assets at June 30, 2015, and December 31, 2014, were as follows:
 
June 30, 2015
 
December 31, 2014
 
Customer
Relationships
 
Other
Intangibles
 
Customer
Relationships
 
Other
Intangibles
 
 
 
 
 
 
 
 
Gross intangible assets
$
123,222

 
$
2,695

 
$
125,448

 
$
3,405

Accumulated amortization
(24,905
)
 
(108
)
 
(19,773
)
 
(487
)
Net intangible assets
$
98,317

 
$
2,587

 
$
105,675

 
$
2,918

At June 30, 2015, $63.2 million in net intangible assets were held in the Domestic segment and $37.7 million were held in the International segment. Amortization expense for intangible assets was $2.4 million and $1.1 million for the three months ended June 30, 2015 and 2014 and $4.9 million and $2.2 million for the six months ended June 30, 2015 and 2014.
Based on the current carrying value of intangible assets subject to amortization, estimated amortization expense is $5.0 million for the remainder of 2015, $10.2 million for 2016, $10.0 million for 2017, $9.4 million for 2018, $9.3 million for 2019 and $9.3 million for 2020.
Note 6—Exit and Realignment Costs
We periodically incur exit and realignment and other charges associated with optimizing our operations, which includes the consolidation of certain distribution and logistics centers, administrative offices and warehouses in the United States and Europe. These charges also include costs associated with our strategic organizational realignment which include management changes, certain professional fees and costs to streamline administrative functions and processes.
Exit and realignment charges by segment for the three and six months ended June 30, 2015 and 2014 were as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2015
 
2014
 
2015
 
2014
Domestic segment
$
(124
)
 
$
2,303

 
$
2,515

 
$
3,596

International segment
4,045

 
1,801

 
8,717

 
3,131

Total exit and realignment charges
$
3,921

 
$
4,104

 
$
11,232

 
$
6,727

The following table summarizes the activity related to exit and realignment cost accruals through June 30, 2015 and 2014:
 
Lease
Obligations
 
Severance and
Other
 
Total
Accrued exit and realignment costs, December 31, 2014
$
3,575

 
$
2,887

 
$
6,462

Provision for exit and realignment activities
256

 
142

 
398

Cash payments, net of sublease income
(385
)
 
(873
)
 
(1,258
)
Accrued exit and realignment costs, March 31, 2015
3,446

 
2,156

 
5,602

Provision for exit and realignment activities
572

 
392

 
964

Cash payments, net of sublease income
(349
)
 
(1,171
)
 
(1,520
)
Accrued exit and realignment costs, June 30, 2015
$
3,669

 
$
1,377

 
$
5,046

 
 
 
 
 
 
Accrued exit and realignment costs, December 31, 2013
$
2,434

 
$
475

 
$
2,909

Provision for exit and realignment activities
532

 
807

 
1,339

Cash payments, net of sublease income
(411
)
 
(327
)
 
(738
)
Accrued exit and realignment costs, March 31, 2014
2,555

 
955

 
3,510

Provision for exit and realignment activities
6

 
2,236

 
2,242

Cash payments, net of sublease income
(383
)
 
(1,095
)
 
(1,478
)
Accrued exit and realignment costs, June 30, 2014
$
2,178

 
$
2,096

 
$
4,274

In addition to the exit and realignment accruals in the preceding table, we also incurred $2.9 million of costs that were expensed as incurred for the three months ended June 30, 2015, including $1.2 million in accelerated amortization of an

10


Table of Contents

information system that has been replaced, $0.8 million in property related costs, $0.7 million in information systems costs, and $0.2 million in other costs. In the first quarter of 2015, we also incurred $6.9 million of costs that were expensed as incurred, including $3.0 million in accelerated amortization of an information system that has been replaced, $1.8 million in facility costs, $1.3 million in labor costs, $0.3 million in information systems costs and $0.5 million in other costs.
For the three months ended June 30, 2014, we recognized $1.9 million in costs that were expensed as incurred, including $0.9 million in property related costs, $0.7 million in labor costs, and $0.2 million in information technology costs. Additional expense in the first quarter of 2014 of $1.3 million were comprised of $0.5 million in relocation costs, $0.5 million in property related costs, and $0.3 million in labor and other costs.
We expect additional exit and realignment charges of approximately $1.7 million over the remainder of 2015 for activities initiated in the Domestic and International segments through June 30, 2015.
Note 7—Retirement Plans
We have a noncontributory, unfunded retirement plan for certain officers and other key employees in the United States. Certain of our foreign subsidiaries also have defined benefit pension plans covering substantially all of their respective employees.
The components of net periodic benefit cost, which are included in selling, general and administrative expenses, for the three and six months ended June 30, 2015 and 2014, were as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2015
 
2014
 
2015
 
2014
Service cost
$
32

 
$
40

 
$
65

 
$
75

Interest cost
464

 
482

 
929

 
965

Recognized net actuarial loss
401

 
202

 
802

 
406

Net periodic benefit cost
$
897

 
$
724

 
$
1,796

 
$
1,446

Certain of our foreign subsidiaries have health and welfare plans covering substantially all of their respective employees. Our expense for these plans totaled $0.5 million and $0.5 million for the three months ended June 30, 2015 and 2014 and $1.0 million and $1.0 million for the six months ended June 30, 2015 and 2014.
Note 8—Debt
We have $275 million of 3.875% senior notes due 2021 (the “2021 Notes”) and $275 million of 4.375% senior notes due 2024 (the “2024 Notes”), with interest payable semi-annually. The 2021 Notes were sold at 99.5% of the principal amount with an effective yield of 3.951%. The 2024 Notes were sold at 99.6% of the principal with an effective yield of 4.422%. We have the option to redeem the 2021 Notes and 2024 Notes in part or in whole prior to maturity at a redemption price equal to the greater of 100% of the principal amount or the present value of the remaining scheduled payments discounted at the Treasury Rate plus 30 basis points. As of June 30, 2015 and December 31, 2014, the estimated fair value of the 2021 Notes was $280.7 million and $275.1 million and the estimated fair value of the 2024 Notes was $279.7 million and $283.9 million, respectively.
We have a Credit Agreement with a $450 million borrowing capacity which extends through September 2019. Under the Amended Credit Agreement, we have the ability to request two one-year extensions and to request an increase in aggregate commitments by up to $200 million. The interest rate on the Amended Credit Agreement, which is subject to adjustment quarterly, is based on the London Interbank Offered Rate (LIBOR), the Federal Funds Rate or the Prime Rate, plus an adjustment based on the better of our debt ratings or leverage ratio (Credit Spread) as defined by the Amended Credit Agreement. We are charged a commitment fee of between 12.5 and 25.0 basis points on the unused portion of the facility. The terms of the Amended Credit Agreement limit the amount of indebtedness that we may incur and require us to maintain ratios for leverage and interest coverage, including on a pro forma basis in the event of an acquisition. Based on our leverage ratio at June 30, 2015, the interest rate under the credit facility is LIBOR plus 1.375%.
At June 30, 2015, we had no borrowings and letters of credit of approximately $5.0 million outstanding under the Amended Credit Agreement, leaving $445 million available for borrowing. We also have a $1.2 million letter of credit outstanding as of June 30, 2015 and December 31, 2014, which supports our facilities leased in Europe.
The Amended Credit Agreement and senior notes contain cross-default provisions which could result in the acceleration of payments due in the event of default of either agreement. We believe we were in compliance with our debt covenants at June 30, 2015.

11


Table of Contents

Note 9—Derivatives
When deemed appropriate, we use derivatives, primarily forward contracts, as a risk management tool to mitigate the potential impact of foreign currency exchange risk. The total notional values of our foreign currency derivatives was $5.7 million at June 30, 2015 and $10.0 million as of December 31, 2014. We do not currently have any derivatives designated as hedging instruments and all gains and losses resulting from changes in the fair value of derivative instruments are immediately recognized into earnings. At June 30, 2015 and December 31, 2014 the fair value of our foreign currency contracts included in other assets on the consolidated balance sheet was $0.9 million and $0.7 million. The impact from changes in the fair value of these foreign currency derivatives included in other operating expense was $0.5 million and other operating income was $0.3 million for the three and six months ended June 30, 2015. We did not hold foreign currency contracts in the first six months of 2014. We consider the risk of counterparty default to be minimal.
Note 10—Income Taxes
The effective tax rate was 41.2% and 42.7% for the three and six months ended June 30, 2015, compared to 41.1% and 40.9% in the same periods of 2014. The change in rate is mainly due to the impact of foreign taxes and the effect of certain acquisition-related costs which are not deductible for tax purposes. The liability for unrecognized tax benefits was $6.0 million at June 30, 2015, and $6.7 million at December 31, 2014. Included in the liability at June 30, 2015 were $3.6 million of tax positions for which ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. In the current quarter, the Company concluded the examinations of our 2012 and 2013 federal income tax returns.  The impact of these examinations on our financial statements was not material.
Note 11—Net Income per Common Share
The following summarizes the calculation of net income per common share attributable to common shareholders for the three and six months ended June 30, 2015 and 2014.
 
Three Months Ended    June 30,
 
Six Months Ended    June 30,
(in thousands, except per share data)
2015
 
2014
 
2015
 
2014
Numerator:
 
 
 
 
 
 
 
Net income
$
24,226

 
$
19,876

 
$
43,166

 
$
45,362

Less: income allocated to unvested restricted shares
(195
)
 
(159
)
 
(359
)
 
(345
)
Net income attributable to common shareholders - basic
24,031

 
19,717

 
42,807

 
45,017

Add: undistributed income attributable to unvested restricted shares - basic
42

 
19

 
63

 
68

Less: undistributed income attributable to unvested restricted shares - diluted
(42
)
 
(19
)
 
(63
)
 
(68
)
Net income attributable to common shareholders - diluted
$
24,031

 
$
19,717

 
$
42,807

 
$
45,017

Denominator:
 
 
 
 
 
 
 
Weighted average shares outstanding - basic
62,226

 
62,311

 
62,281

 
62,271

Dilutive shares - stock options

 
5

 
1

 
9

Weighted average shares outstanding - diluted
62,226

 
62,316

 
62,282

 
62,280

Net income per share attributable to common shareholders:
 
 
 
 
 
 
 
Basic
$
0.39

 
$
0.32

 
$
0.69

 
$
0.72

Diluted
$
0.39

 
$
0.32

 
$
0.69

 
$
0.72

Note 12—Shareholders’ Equity
Our Board of Directors has authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2017. The program is intended, in part, to offset shares issued in conjunction with our stock incentive plans and return capital to shareholders. The program may be suspended or discontinued at any time. During the six months ended June 30, 2015, we repurchased in open-market transactions and retired approximately 0.2 million shares of our common stock for an aggregate of $7.4 million, or an average price per share of $33.82. As of June 30, 2015, we have approximately $82.6 million remaining under the repurchase program. We have elected to allocate any excess of share repurchase price over par value to retained earnings.

12


Table of Contents

Note 13—Accumulated Other Comprehensive Income
The following table shows the changes in accumulated other comprehensive income (loss) by component for the three and six months ended June 30, 2015 and 2014: 
 
Defined Benefit
Pension
Plans
 
Currency
Translation
Adjustments
 
Other
 
Total
Accumulated other comprehensive income (loss), March 31, 2015
$
(10,065
)
 
$
(41,588
)
 
$
7

 
$
(51,646
)
Other comprehensive income (loss) before reclassifications

 
6,606

 

 
6,606

Income tax

 

 

 

Other comprehensive income (loss) before reclassifications, net of tax

 
6,606

 

 
6,606

Amounts reclassified from accumulated other comprehensive income (loss)
401

 

 
(8
)
 
393

Income tax
(141
)
 

 

 
(141
)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax
260



 
(8
)
 
252

Other comprehensive income (loss)
260

 
6,606

 
(8
)
 
6,858

Accumulated other comprehensive income (loss), June 30, 2015
$
(9,805
)
 
$
(34,982
)
 
$
(1
)
 
$
(44,788
)
 
 
 
 
 
 
 
 
Accumulated other comprehensive income (loss), March 31, 2014
$
(6,372
)
 
$
16,359

 
$
146

 
$
10,133

Other comprehensive income (loss) before reclassifications

 
(570
)
 
29

 
(541
)
Income tax

 

 

 

Other comprehensive income (loss) before reclassifications, net of tax

 
(570
)
 
29

 
(541
)
Amounts reclassified from accumulated other comprehensive income (loss)
202

 

 
(22
)
 
180

Income tax
(90
)
 

 
8

 
(82
)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax
112

 

 
(14
)
 
98

Other comprehensive income (loss)
112

 
(570
)
 
15

 
(443
)
Accumulated other comprehensive income (loss), June 30, 2014
$
(6,260
)
 
$
15,789

 
$
161

 
$
9,690

 
 
 
 
 
 
 
 
 


13


Table of Contents

 
Defined Benefit
Pension
Plans
 
Currency
Translation
Adjustments
 
Other
 
Total
Accumulated other comprehensive income (loss), December 31, 2014
$
(10,323
)
 
$
(13,647
)
 
$
(31
)
 
$
(24,001
)
Other comprehensive income (loss) before reclassifications

 
(21,335
)
 

 
(21,335
)
Income tax

 

 

 

Other comprehensive income (loss) before reclassifications, net of tax

 
(21,335
)
 

 
(21,335
)
Amounts reclassified from accumulated other comprehensive income (loss)
803

 

 
30

 
833

Income tax
(285
)
 

 

 
(285
)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax
518

 

 
30

 
548

Other comprehensive income (loss)
518

 
(21,335
)
 
30

 
(20,787
)
Accumulated other comprehensive income (loss), June 30, 2015
$
(9,805
)
 
$
(34,982
)
 
$
(1
)
 
$
(44,788
)
 
 
 
 
 
 
 
 
Accumulated other comprehensive income (loss), December 31, 2013
$
(6,479
)
 
$
15,892

 
$
155

 
$
9,568

Other comprehensive income (loss) before reclassifications

 
(103
)
 
31

 
(72
)
Income tax

 

 

 

Other comprehensive income (loss) before reclassifications, net of tax

 
(103
)
 
31

 
(72
)
Amounts reclassified from accumulated other comprehensive income (loss)
405

 

 
(41
)
 
364

Income tax
(186
)
 

 
16

 
(170
)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax
219

 

 
(25
)
 
194

Other comprehensive income (loss)
219

 
(103
)
 
6

 
122

Accumulated other comprehensive income (loss), June 30, 2014
$
(6,260
)
 
$
15,789

 
$
161

 
$
9,690

We include amounts reclassified out of accumulated other comprehensive income related to defined benefit pension plans as a component of net periodic pension cost recorded in selling, general & administrative expenses. For the three and six months ended June 30, 2015, we reclassified $0.4 million and $0.8 million of actuarial net losses. For the three and six months ended June 30, 2014, we reclassified $0.2 million and $0.4 million of actuarial net losses.
Note 14—Commitments and Contingencies
Prior to exiting the direct-to-consumer business in January 2009, we received reimbursements from Medicare, Medicaid, and private healthcare insurers for certain customer billings. We are subject to audits of these reimbursements for up to seven years from the date of the service.
In the first quarter of 2015, we settled our dispute and terminated the service contract with a customer in the United Kingdom. As part of the settlement, we entered into a transition agreement for the transfer of services back to this customer and paid approximately $3.9 million that was fully accrued at December 31, 2014. Substantially all outstanding accounts receivable as of December 31, 2014 related to this contract have been received.
Note 15—Segment Information
We evaluate the performance of our segments based on their operating earnings excluding acquisition-related and exit and realignment charges, certain purchase price fair value adjustments, and other substantive items that, either as a result of their nature or size, would not be expected to occur as part of the our normal business operations on a regular basis.


14


Table of Contents

The following tables present financial information by segment:
 
Three Months Ended   June 30,
 
Six Months Ended   June 30,
 
2015
 
2014
 
2015
 
2014
Net revenue:
 
 
 
 
 
 
 
Domestic
$
2,317,661

 
$
2,187,535

 
$
4,603,296

 
$
4,336,451

International
104,506

 
118,323

 
210,067

 
225,788

Consolidated net revenue
$
2,422,167

 
$
2,305,858

 
$
4,813,363

 
$
4,562,239

 
 
 
 
 
 
 
 
Operating earnings (loss):
 
 
 
 
 
 
 
Domestic
$
52,390

 
$
48,317

 
$
102,901

 
$
101,053

International
1,177

 
(3,623
)
 
1,557

 
(6,811
)
Acquisition-related and exit and realignment charges (1)
(5,707
)
 
(7,593
)
 
(15,623
)
 
(10,855
)
Consolidated operating earnings
$
47,860

 
$
37,101

 
$
88,835

 
$
83,387

 
 
 
 
 
 
 
 
Depreciation and amortization:
 
 
 
 
 
 
 
Domestic
$
10,504

 
$
8,812

 
$
21,242

 
$
17,787

International
5,277

 
5,080

 
10,708

 
9,969

Consolidated depreciation and amortization
$
15,781

 
$
13,892

 
$
31,950

 
$
27,756

 
 
 
 
 
 
 
 
Capital expenditures:
 
 
 
 
 
 
 
Domestic
$
3,384

 
$
18,858

 
$
12,035

 
$
29,033

International
7,875

 
5,737

 
10,790

 
9,790

Consolidated capital expenditures
$
11,259

 
$
24,595

 
$
22,825

 
$
38,823

 
 
June 30, 2015
 
December 31, 2014
Total assets:
 
 
 
Domestic
$
2,130,996

 
$
2,139,972

International
462,941

 
538,662

Segment assets
2,593,937

 
2,678,634

Cash and cash equivalents
200,969

 
56,772

Consolidated total assets
$
2,794,906

 
$
2,735,406

(1) The three and six months ended June 30, 2015 include $1.2 million and $4.2 million, respectively in accelerated amortization related to an information system that is being replaced.


15


Table of Contents

Note 16—Condensed Consolidating Financial Information
The following tables present condensed consolidating financial information for: Owens & Minor, Inc. (O&M); the guarantors of Owens & Minor, Inc.’s 2021 Notes and 2024 Notes, on a combined basis; and the non-guarantor subsidiaries of the 2021 Notes and 2024 Notes, on a combined basis. The guarantor subsidiaries are 100% owned by Owens & Minor, Inc. Separate financial statements of the guarantor subsidiaries are not presented because the guarantees by our guarantor subsidiaries are full and unconditional, as well as joint and several, and we believe the condensed consolidating financial information is more meaningful in understanding the financial position, results of operations and cash flows of the guarantor subsidiaries.
Three Months Ended June 30, 2015
Owens &
Minor, Inc.
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statements of Income
 
 
 
 
 
 
 
 
 
Net revenue
$

 
$
2,279,725

 
$
178,844

 
$
(36,402
)
 
$
2,422,167

Cost of goods sold

 
2,064,515

 
95,570

 
(36,255
)
 
2,123,830

Gross margin

 
215,210

 
83,274

 
(147
)
 
298,337

Selling, general and administrative expenses
626

 
160,348

 
70,524

 

 
231,498

Acquisition-related and exit and realignment charges

 
256

 
5,451

 

 
5,707

Depreciation and amortization

 
8,910

 
6,550

 

 
15,460

Other operating income, net

 
(1,354
)
 
(834
)
 

 
(2,188
)
Operating earnings (loss)
(626
)
 
47,050

 
1,583

 
(147
)
 
47,860

Interest expense (income), net
6,938

 
(233
)
 
(25
)
 

 
6,680

Income (loss) before income taxes
(7,564
)
 
47,283

 
1,608

 
(147
)
 
41,180

Income tax (benefit) provision

 
16,973

 
(19
)
 

 
16,954

Equity in earnings of subsidiaries
31,790

 

 

 
(31,790
)
 

Net income (loss)
24,226

 
30,310

 
1,627

 
(31,937
)
 
24,226

Other comprehensive income (loss)
6,858

 
(21,839
)
 
28,696

 
(6,857
)
 
6,858

Comprehensive income (loss)
$
31,084

 
$
8,471

 
$
30,323

 
$
(38,794
)
 
$
31,084


16


Table of Contents

Three Months Ended June 30, 2014
Owens &
Minor, Inc.
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statements of Income
 
 
 
 
 
 
 
 
 
Net revenue
$

 
$
2,187,130

 
$
137,683

 
$
(18,955
)
 
$
2,305,858

Cost of goods sold

 
1,978,815

 
63,299

 
(18,528
)
 
2,023,586

Gross margin

 
208,315

 
74,384

 
(427
)
 
282,272

Selling, general and administrative expenses
61

 
152,122

 
73,655

 

 
225,838

Acquisition-related and exit and realignment charges

 
3,886

 
3,707

 

 
7,593

Depreciation and amortization
2

 
8,790

 
5,100

 

 
13,892

Other operating income, net

 
(814
)
 
(1,338
)
 

 
(2,152
)
Operating earnings (loss)
(63
)
 
44,331

 
(6,740
)
 
(427
)
 
37,101

Interest expense (income), net
2,924

 
791

 
(373
)
 

 
3,342

Income (loss) before income taxes
(2,987
)
 
43,540

 
(6,367
)
 
(427
)
 
33,759

Income tax (benefit) provision
(1,200
)
 
17,808

 
(2,725
)
 

 
13,883

Equity in earnings of subsidiaries
21,663

 

 

 
(21,663
)
 

Net income (loss)
19,876

 
25,732

 
(3,642
)
 
(22,090
)
 
19,876

Other comprehensive income (loss)
(443
)
 
111

 
(570
)
 
459

 
(443
)
Comprehensive income (loss)
$
19,433

 
$
25,843

 
$
(4,212
)
 
$
(21,631
)
 
$
19,433

Six Months Ended June 30, 2015
Owens &
Minor, Inc.
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statements of Income
 
 
 
 
 
 
 
 
 
Net revenue
$

 
$
4,529,430

 
$
360,204

 
$
(76,271
)
 
$
4,813,363

Cost of goods sold

 
4,098,327

 
195,608

 
(76,510
)
 
4,217,425

Gross margin

 
431,103

 
164,596

 
239

 
595,938

Selling, general and administrative expenses
665

 
320,925

 
143,733

 

 
465,323

Acquisition-related and exit and realignment charges

 
3,833

 
11,790

 

 
15,623

Depreciation and amortization

 
18,014

 
13,315

 

 
31,329

Other operating income, net

 
(2,331
)
 
(2,841
)
 

 
(5,172
)
Operating earnings (loss)
(665
)
 
90,662

 
(1,401
)
 
239

 
88,835

Interest expense (income), net
12,885

 
581

 
94

 

 
13,560

Income (loss) before income taxes
(13,550
)
 
90,081

 
(1,495
)
 
239

 
75,275

Income tax (benefit) provision
(773
)
 
31,759

 
1,123

 

 
32,109

Equity in earnings of subsidiaries
55,943

 

 

 
(55,943
)
 

Net income (loss)
43,166

 
58,322

 
(2,618
)
 
(55,704
)
 
43,166

Other comprehensive income (loss)
(20,787
)
 
(21,335
)
 
548

 
20,787

 
(20,787
)
Comprehensive income (loss)
$
22,379

 
$
36,987

 
$
(2,070
)
 
$
(34,917
)
 
$
22,379


17


Table of Contents

Six Months Ended June 30, 2014
Owens &
Minor, Inc.
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statements of Income
 
 
 
 
 
 
 
 
 
Net revenue
$

 
$
4,335,495

 
$
257,558

 
$
(30,814
)
 
$
4,562,239

Cost of goods sold

 
3,918,280

 
110,897

 
(30,406
)
 
3,998,771

Gross margin

 
417,215

 
146,661

 
(408
)
 
563,468

Selling, general and administrative expenses
14

 
306,372

 
145,062

 

 
451,448

Acquisition-related and exit and realignment charges

 
5,180

 
5,675

 

 
10,855

Depreciation and amortization
1

 
17,741

 
10,014

 

 
27,756

Other operating income, net

 
(7,877
)
 
(2,101
)
 

 
(9,978
)
Operating earnings (loss)
(15
)
 
95,799

 
(11,989
)
 
(408
)
 
83,387

Interest expense (income), net
5,399

 
2,034

 
(844
)
 

 
6,589

Income (loss) before income taxes
(5,414
)
 
93,765

 
(11,145
)
 
(408
)
 
76,798

Income tax (benefit) provision
(2,155
)
 
37,994

 
(4,403
)
 

 
31,436

Equity in earnings of subsidiaries
48,621

 

 

 
(48,621
)
 

Net income (loss)
45,362

 
55,771

 
(6,742
)
 
(49,029
)
 
45,362

Other comprehensive income (loss)
122

 
218

 
(103
)
 
(115
)
 
122

Comprehensive income (loss)
$
45,484

 
$
55,989

 
$
(6,845
)
 
$
(49,144
)
 
$
45,484



18


Table of Contents

June 30, 2015
Owens &
Minor, Inc.
 
Guarantor
Subsidiaries
 
Non-
guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Balance Sheets
 
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
105,427

 
$
46,639

 
$
48,903

 
$

 
$
200,969

Accounts and notes receivable, net

 
485,256

 
105,346

 
(9,863
)
 
580,739

Merchandise inventories

 
852,396

 
55,272

 
(4,167
)
 
903,501

Other current assets
299

 
94,214

 
179,717

 
1,251

 
275,481

Total current assets
105,726

 
1,478,505

 
389,238

 
(12,779
)
 
1,960,690

Property and equipment, net

 
108,373

 
110,999

 

 
219,372

Goodwill, net

 
247,271

 
174,489

 

 
421,760

Intangible assets, net

 
14,768

 
86,136

 

 
100,904

Due from O&M and subsidiaries

 
513,448

 

 
(513,448
)
 

Advances to and investment in consolidated subsidiaries
1,897,461

 

 

 
(1,897,461
)
 

Other assets, net
4,347

 
62,413

 
25,420

 

 
92,180

Total assets
$
2,007,534

 
$
2,424,778

 
$
786,282

 
$
(2,423,688
)
 
$
2,794,906

Liabilities and equity
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
Accounts payable
$

 
$
713,907

 
$
48,470

 
$
(8,882
)
 
$
753,495

Accrued payroll and related liabilities

 
23,485

 
11,312

 

 
34,797

Deferred income taxes

 
43,160

 
(1,782
)
 

 
41,378

Other accrued liabilities
7,004

 
99,024

 
182,404

 

 
288,432

Total current liabilities
7,004

 
879,576

 
240,404

 
(8,882
)
 
1,118,102

Long-term debt, excluding current portion
547,905

 
5,395

 
21,323

 

 
574,623

Due to O&M and subsidiaries
475,498

 

 
77,464

 
(552,962
)
 

Intercompany debt

 
138,890

 

 
(138,890
)
 

Deferred income taxes

 
32,974

 
29,308

 

 
62,282

Other liabilities

 
55,155

 
7,617

 

 
62,772

Total liabilities
1,030,407

 
1,111,990

 
376,116

 
(700,734
)
 
1,817,779

Equity
 
 
 
 
 
 
 
 
 
Common stock
126,036

 

 

 

 
126,036

Paid-in capital
205,727

 
241,877

 
514,314

 
(756,191
)
 
205,727

Retained earnings (deficit)
690,152

 
1,080,701

 
(69,099
)
 
(1,011,602
)
 
690,152

Accumulated other comprehensive income (loss)
(44,788
)
 
(9,790
)
 
(35,049
)
 
44,839

 
(44,788
)
Total equity
977,127

 
1,312,788

 
410,166

 
(1,722,954
)
 
977,127

Total liabilities and equity
$
2,007,534

 
$
2,424,778

 
$
786,282

 
$
(2,423,688
)
 
$
2,794,906



19


Table of Contents

December 31, 2014
Owens &
Minor, Inc.
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Balance Sheets
 
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
22,013

 
$
3,912

 
$
30,847

 
$

 
$
56,772

Accounts and notes receivable, net

 
519,951

 
144,463

 
(38,222
)
 
626,192

Merchandise inventories

 
816,915

 
60,061

 
(4,519
)
 
872,457

Other current assets
(24,748
)
 
90,733

 
224,220

 
25,080

 
315,285

Total current assets
(2,735
)
 
1,431,511

 
459,591

 
(17,661
)
 
1,870,706

Property and equipment, net

 
110,076

 
122,903

 

 
232,979

Goodwill, net

 
247,271

 
176,005

 

 
423,276

Intangible assets, net

 
15,805

 
92,788

 

 
108,593

Due from O&M and subsidiaries

 
357,304

 

 
(357,304
)
 

Advances to and investments in consolidated subsidiaries
1,893,767

 

 

 
(1,893,767
)
 

Other assets, net
4,637

 
66,836

 
28,379

 

 
99,852

Total assets
$
1,895,669

 
$
2,228,803

 
$
879,666

 
$
(2,268,732
)
 
$
2,735,406

Liabilities and equity
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
Accounts payable
$

 
$
567,285

 
$
54,898

 
$
(13,337
)
 
$
608,846

Accrued payroll and related liabilities

 
16,434

 
15,073

 

 
31,507

Deferred income taxes

 
39,667

 
(1,688
)
 

 
37,979

Other current liabilities
6,441

 
83,698

 
236,084

 

 
326,223

Total current liabilities
6,441

 
707,084

 
304,367

 
(13,337
)
 
1,004,555

Long-term debt, excluding current portion
547,763

 
39,915

 
20,873

 

 
608,551

Due to O&M and subsidiaries
350,627

 

 
77,788

 
(428,415
)
 

Intercompany debt

 
138,890

 

 
(138,890
)
 

Deferred income taxes

 
33,162

 
30,739

 

 
63,901

Other liabilities

 
55,794

 
11,767

 

 
67,561

Total liabilities
904,831

 
974,845

 
445,534

 
(580,642
)
 
1,744,568

Equity
 
 
 
 
 
 
 
 

Common stock
126,140

 

 

 

 
126,140

Paid-in capital
202,934

 
241,877

 
514,314

 
(756,191
)
 
202,934

Retained earnings (deficit)
685,765

 
1,022,379

 
(66,479
)
 
(955,900
)
 
685,765

Accumulated other comprehensive income (loss)
(24,001
)
 
(10,298
)
 
(13,703
)
 
24,001

 
(24,001
)
Total equity
990,838

 
1,253,958

 
434,132

 
(1,688,090
)
 
990,838

Total liabilities and equity
$
1,895,669

 
$
2,228,803

 
$
879,666

 
$
(2,268,732
)
 
$
2,735,406




 


20


Table of Contents

Six Months Ended June 30, 2015
Owens &
Minor, Inc.
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statements of Cash Flows
 
 
 
 
 
 
 
 
 
Operating activities:
 
 
 
 
 
 
 
 
 
Net income (loss)
$
43,166

 
$
58,322

 
$
(2,618
)
 
$
(55,704
)
 
$
43,166

Adjustments to reconcile net income to cash provided by (used for) operating activities:
 
 
 
 
 
 
 
 

Equity in earnings of subsidiaries
(55,943
)
 

 

 
55,943

 

Depreciation and amortization

 
17,741

 
18,397

 

 
36,138

Share-based compensation expense

 
5,048

 

 

 
5,048

Provision for losses on accounts and notes receivable

 
(36
)
 
77

 

 
41

Deferred income tax expense (benefit)

 
2,376

 
616

 

 
2,992

Changes in operating assets and liabilities:
 
 
 
 
 
 
 
 

Accounts and notes receivable

 
35,566

 
(180
)
 
6,236

 
41,622

Merchandise inventories

 
(35,481
)
 
1,193

 
2,422

 
(31,866
)
Accounts payable

 
146,622

 
5,798

 
(6,738
)
 
145,682

Net change in other assets and liabilities
(148
)
 
14,338

 
(9,260
)
 
(2,159
)
 
2,771

Other, net
429

 
726

 
41

 

 
1,196

Cash provided by (used for) operating activities
(12,496
)
 
245,222

 
14,064

 

 
246,790

Investing activities:
 
 
 
 
 
 
 
 


Additions to property and equipment

 
(9,292
)
 
(2,717
)
 

 
(12,009
)
Additions to computer software and intangible assets

 
(2,068
)
 
(8,748
)
 

 
(10,816
)
Proceeds from the sale of property and equipment

 
60

 
777

 

 
837

Cash used for investing activities

 
(11,300
)
 
(10,688
)
 

 
(21,988
)
Financing activities:
 
 
 
 
 
 
 
 

Change in intercompany advances
135,627

 
(155,951
)
 
20,324

 

 

Repayment of revolving credit facility

 
(33,700
)
 

 

 
(33,700
)
Change in bank overdraft

 

 
1,530

 

 
1,530

Cash dividends paid
(31,867
)
 

 

 

 
(31,867
)
Repurchases of common stock
(7,440
)
 

 

 

 
(7,440
)
Excess tax benefits related to share-based compensation
457

 

 

 

 
457

Other, net
(867
)
 
(1,544
)
 
(2,701
)
 

 
(5,112
)
Cash provided by (used for) financing activities
95,910

 
(191,195
)
 
19,153

 

 
(76,132
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(4,473
)
 

 
(4,473
)
Net increase (decrease) in cash and cash equivalents
83,414

 
42,727

 
18,056

 

 
144,197

Cash and cash equivalents at beginning of period
22,013

 
3,912

 
30,847

 

 
56,772

Cash and cash equivalents at end of period
$
105,427

 
$
46,639

 
$
48,903

 
$

 
$
200,969


21


Table of Contents

 
Six months ended June 30, 2014
Owens &
Minor, Inc.
 
Guarantor
Subsidiaries
 
Non-guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statements of Cash Flows
 
 
 
 
 
 
 
 
 
Operating activities:
 
 
 
 
 
 
 
 
 
Net income (loss)
$
45,362

 
$
55,771

 
$
(6,742
)
 
$
(49,029
)
 
$
45,362

Adjustments to reconcile net income to cash provided by (used for) operating activities:
 
 
 
 
 
 
 
 

Equity in earnings of subsidiaries
(48,621
)
 

 

 
48,621

 

Depreciation and amortization
1

 
17,741

 
10,014

 

 
27,756

Share-based compensation expense

 
4,190

 

 

 
4,190

Provision for losses on accounts and notes receivable

 
146

 
188

 

 
334

Deferred income tax expense (benefit)

 
(4,117
)
 
(1,034
)
 

 
(5,151
)
Changes in operating assets and liabilities:
 
 
 
 
 
 
 
 

Accounts and notes receivable

 
28,286

 
428

 
(237
)
 
28,477

Merchandise inventories

 
(38,733
)
 
(10,248
)
 
406

 
(48,575
)
Accounts payable

 
54,860

 
(177
)
 
239

 
54,922

Net change in other assets and liabilities
(952
)
 
(15,272
)
 
(16,541
)
 

 
(32,765
)
Other, net
(776
)
 
(280
)
 
(22
)
 

 
(1,078
)
Cash provided by (used for) operating activities
(4,986
)
 
102,592


(24,134
)



73,472

Investing activities:
 
 
 
 
 
 
 
 


Proceeds from the sale of investment


 
1,937

 


 


 
1,937

Additions to property and equipment

 
(16,777
)
 
(8,880
)
 

 
(25,657
)
Additions to computer software and intangible assets

 
(12,256
)
 
(910
)
 

 
(13,166
)
Proceeds from the sale of property and equipment

 
35

 
10

 

 
45

Cash used for investing activities

 
(27,061
)
 
(9,780
)
 

 
(36,841
)
Financing activities:

 

 

 

 

Change in intercompany advances
28,847

 
(62,995
)
 
34,148

 

 

Cash dividends paid
(31,564
)
 

 

 

 
(31,564
)
Repurchases of common stock
(9,448
)
 

 

 

 
(9,448
)
Excess tax benefits related to share-based compensation
444

 

 

 

 
444

Proceeds from exercise of stock options
1,180

 

 

 

 
1,180

Purchase of noncontrolling interest

 

 
(1,500
)
 

 
(1,500
)
Other, net
(2,072
)
 
(1,450
)
 
(919
)
 

 
(4,441
)
Cash provided by (used for) financing activities
(12,613
)
 
(64,445
)

31,729




(45,329
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(1,180
)
 

 
(1,180
)
Net increase (decrease) in cash and cash equivalents
(17,599
)

11,086


(3,365
)



(9,878
)
Cash and cash equivalents at beginning of period
74,391

 
2,012

 
25,502

 

 
101,905

Cash and cash equivalents at end of period
$
56,792

 
$
13,098

 
$
22,137

 
$

 
$
92,027


22


Table of Contents

Note 17—Recent Accounting Pronouncements
There has been no change in our significant accounting policies from those contained in our Annual Report on Form 10-K for the year ended December 31, 2014. There are no new accounting pronouncements that we anticipate will have a material impact on our financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis describes results of operations and material changes in the financial condition of Owens & Minor, Inc. and its subsidiaries since December 31, 2014. Trends of a material nature are discussed to the extent known and considered relevant. This discussion should be read in conjunction with the consolidated financial statements, related notes thereto, and management’s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the year ended December 31, 2014.
Overview
Owens & Minor, Inc., along with its subsidiaries, (we, us, or our) is a leading national distributor of name-brand medical and surgical supplies and a healthcare logistics company. We report our business under two segments: Domestic and International. The Domestic segment includes all functions relating to our role as a medical supply logistics company providing distribution, packaging and logistics services to healthcare providers and manufacturers in the United States. The International segment consists of our European third-party logistics and packaging businesses. Segment financial information is provided in Note 15 of Notes to Consolidated Financial Statements included in this quarterly report.
Financial highlights. The following table provides a reconciliation of reported operating earnings, net income and net income per diluted common share to non-GAAP measures used by management.
 
Three Months Ended June 30,
 
Six Months Ended   June 30,
(Dollars in thousands except per share data)
2015
 
2014
 
2015
 
2014
Operating earnings, as reported (GAAP)
$
47,860

 
$
37,101

 
$
88,835

 
$
83,387

Acquisition-related and exit and realignment charges
5,707

 
7,593

 
15,623

 
10,855

Operating earnings, adjusted (non-GAAP) (Adjusted Operating Earnings)
$
53,567

 
$
44,694

 
$
104,458

 
$
94,242

Adjusted Operating Earnings as a percent of revenue (non-GAAP)
2.21
%
 
1.94
%
 
2.17
%
 
2.07
%
Net income, as reported (GAAP)
$
24,226

 
$
19,876

 
$
43,166

 
$
45,362

Acquisition-related and exit and realignment charges, net of tax
4,869

 
5,095

 
13,461

 
7,317

Net income, adjusted (non-GAAP) (Adjusted Net Income)
$
29,095

 
$
24,971

 
$
56,627

 
$
52,679

Net income per diluted common share, as reported (GAAP)
$
0.39

 
$
0.32

 
$
0.69

 
$
0.72

Acquisition-related and exit and realignment charges, per diluted common share
0.07

 
0.08

 
0.21

 
0.12

Net income per diluted common share, adjusted (non-GAAP)(Adjusted EPS)
$
0.46

 
$
0.40

 
$
0.90

 
$
0.84

Adjusted EPS (non-GAAP) was $0.46 and $0.90 for the three and six months ended June 30, 2015, $0.06 higher than the prior year for both periods. Domestic segment operating earnings increased by $4.1 million to $52.4 million in the second quarter and increased $1.8 million to $102.9 million for the year-to-date period when compared to prior year. The six month period of 2014 included the recovery of $5.3 million related to the settlement of a direct purchaser anti-trust class action lawsuit. The International segment improved $4.8 million in the three month period ended June 30, 2015 to operating income of $1.2 million and improved $8.4 million on a year-to-date basis to operating income of $1.6 million.
Use of Non-GAAP Measures
This management’s discussion and analysis contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP). In general, the measures exclude items and charges that (i) management does not believe reflect our core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate our performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation.

23


Table of Contents

Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on our financial and operating results and in comparing our performance to that of our competitors. However, the non-GAAP financial measures used by us may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.
The non-GAAP financial measures disclosed by us should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated.
Acquisition-related charges were $1.8 million and $4.4 million for the three and six months ended June 30, 2015 compared to $3.5 million and $4.1 million for the same periods of 2014. Current year charges consist primarily of costs to continue the integration of Medical Action and ArcRoyal which were acquired in the fourth quarter of 2014 including certain severance and contractual payments to former management and costs to transition information technology and other administrative functions. Prior year charges consisted primarily of transaction costs incurred to perform due diligence and analysis related to these acquisitions, as well as costs in Movianto to resolve certain contingencies with the former owner.
Exit and realignment charges of $3.9 million and $11.2 million for the three and six months ended June 30, 2015 were associated with optimizing our operations and included the consolidation of distribution and logistics centers and closure of offsite warehouses in the United States and Europe, as well as other costs associated with our strategic organizational realignment which include certain professional fees and costs to streamline administrative functions and processes in Europe. Similar charges in 2014 totaled $4.1 million and $6.7 million in the comparable periods.
These charges have been tax effected in the preceding table by determining the income tax rate depending on the amount of charges incurred in different tax jurisdictions and the deductibility of those charges for income tax purposes. Unless otherwise stated, our analysis hereinafter excludes acquisition-related and exit and realignment charges. More information about these charges is provided in Notes 3 and 6 of Notes to Consolidated Financial Statements included in this quarterly report.
Results of Operations
Net revenue.
 
Three Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
Domestic
$
2,317,661

 
$
2,187,535

 
$
130,126

 
5.9
 %
International
104,506

 
118,323

 
(13,817
)
 
(11.7
)%
Net revenue
$
2,422,167

 
$
2,305,858

 
$
116,309

 
5.0
 %
 
Six Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
Domestic
$
4,603,296

 
$
4,336,451

 
$
266,845

 
6.2
 %
International
210,067

 
225,788

 
(15,721
)
 
(7.0
)%
Net revenue
$
4,813,363

 
$
4,562,239

 
$
251,124

 
5.5
 %
Consolidated net revenue improved in the three and six month periods ended June 30, 2015 as a result of strong growth in our Domestic segment. Excluding the impact of the 2014 fourth quarter acquisition, Domestic net revenue increased by 4.2% for the quarter and 4.5% year-to-date. The continued trend of growth in our existing large healthcare provider customer accounts and new business exceeded declines from smaller customers and lost business when compared to prior year. Domestic segment growth rates are impacted by ongoing market trends including healthcare utilization rates. The decrease in the International segment net revenue was driven by unfavorable foreign currency translation impacts of $15.7 million and $30.5 million for the three and six months ended June 30, 2015. On a constant currency basis, excluding the impact of the 2014 packaging acquisition and the transition of a customer from buy/sell to a fee-for-service arrangement, net revenues in the International segment were essentially flat for the quarter and year-to-date periods compared to prior year. Fee-for-service business generally represents approximately two-thirds of net revenue in the International segment.

24


Table of Contents

Cost of goods sold.
 
Three Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
Cost of goods sold
$
2,123,830

 
$
2,023,586

 
$
100,244

 
5.0
%
 
Six Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
Cost of goods sold
$
4,217,425

 
$
3,998,771

 
$
218,654

 
5.5
%
Cost of goods sold includes the cost of the product (net of supplier incentives and cash discounts) and all costs incurred for shipments of products from manufacturers to our distribution centers for all customer arrangements where we are the primary obligor, bear risk of general and physical inventory loss and carry all credit risk associated with sales. These are sometimes referred to as distribution or buy/sell contracts. Beginning in the fourth quarter of 2014, cost of goods sold also includes direct and certain indirect labor, material and overhead costs associated with our packaging operations. There is no cost of goods sold associated with our fee-for-service business. As a result of the increase in sales activity through our distribution and packaging businesses, cost of goods sold increased from prior year by $100.2 million and $218.7 million for the three and six month periods ended June 30, 2015, respectively.
Gross margin.
 
Three Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
Gross margin
$
298,337

 
$
282,272

 
$
16,065

 
5.7
%
As a % of net revenue
12.32
%
 
12.24
%
 
 
 
 
 
Six Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
Gross margin
$
595,938

 
$
563,468

 
$
32,470

 
5.8
%
As a % of net revenue
12.38
%
 
12.35
%
 
 
 
 
The increases in gross margin for the quarter and year-to-date periods of 2015 compared to the prior year were largely attributable to revenue growth in the Domestic segment as described above, as well as benefits from certain supplier product price changes in the second quarter of 2015. The International segment also experienced an increase in gross margin from prior year resulting from the packaging acquisition and growth in fee-for-service business though these benefits were offset by $12.6 million in the quarter and $23.8 million year-to-date in unfavorable impacts from foreign currency translation.
Operating expenses.
 
Three Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
SG&A expenses
$
231,498

 
$
225,838

 
$
5,660

 
2.5
%
As a % of net revenue
9.56
%
 
9.79
%
 

 

Depreciation and amortization
$
15,460

 
$
13,892

 
$
1,568

 
11.3
%
Other operating income, net
$
(2,188
)
 
$
(2,152
)
 
$
(36
)
 
1.7
%
 
Six Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
SG&A expenses
$
465,323

 
$
451,448

 
$
13,875

 
3.1
 %
As a % of net revenue
9.67
%
 
9.90
%
 
 
 
 
Depreciation and amortization
$
31,329

 
$
27,756

 
$
3,573

 
12.9
 %
Other operating income, net
$
(5,172
)
 
$
(9,978
)
 
$
4,806

 
(48.2
)%

25


Table of Contents

Selling, general and administrative (SG&A) expenses include labor and warehousing costs associated with our distribution and logistics services and all costs associated with our fee-for-service arrangements. Shipping and handling costs are included in SG&A expenses and include costs to store, to move, and to prepare products for shipment, as well as costs to deliver products to customers. The costs to convert new customers to our information systems are generally incurred prior to the recognition of revenues from the new customers.
The increases in SG&A expenses compared to the prior year periods were largely attributable to increased expenses associated with incremental sales activity in the Domestic segment as well as increases from the 2014 acquisitions in both segments, partially offset by favorable foreign currency translation impacts of $11.4 million for the quarter and $22.1 million year-to-date. The Domestic segment also incurred $0.4 million and $0.8 million for the three and six month periods ended June 30, 2015 in costs associated with our previously announced CEO search which includes professional fees, consulting, meeting and travel expenses and other costs associated with the leadership succession plan.
Depreciation and amortization expense increased in both periods of 2015 compared to the prior year as a result of property, equipment and intangible assets acquired with business combinations in the fourth quarter of 2014. In connection with our packaging businesses, approximately $0.3 million and $0.6 million in depreciation for the three and six months ended June 20, 2015 is also included in cost of goods sold. Additional amortization of $1.2 million and $4.2 million related to the accelerated amortization of an information system which has been replaced in the International segment is included in acquisition-related and exit and realignment charges for the current quarter and year-to-date periods.
The decrease in other operating income, net for the six months ended June 30, 2015 compared to 2014 was attributed primarily to the benefit in the prior year of $5.3 million from the settlement of a direct purchaser anti-trust class action lawsuit which did not re-occur in the current year.
Interest expense, net
 
Three Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
Interest expense, net
$
6,680

 
$
3,342

 
$
3,338

 
99.9
%
Effective interest rate
4.81
%
 
6.12
%
 
 
 
 
 
Six Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
Interest expense, net
$
13,560

 
$
6,589

 
$
6,971

 
105.8
%
Effective interest rate
4.74
%
 
6.10
%
 
 
 
 
The increases in interest expense in the three and six months ended June 30, 2015 compared to the same periods of 2014 were the result of the new Senior Notes issued on September 16, 2014.
Income taxes.
 
Three Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
Income tax provision
$
16,954

 
$
13,883

 
$
3,071

 
22.1
%
Effective tax rate
41.2
%
 
41.1
%
 
 
 
 
 
Six Months Ended June 30,
 
Change
(Dollars in thousands)
2015
 
2014
 
$
 
%
Income tax provision
$
32,109

 
$
31,436

 
$
673

 
2.1
%
Effective tax rate
42.7
%
 
40.9
%
 
 
 
 
The change in the provision for income taxes compared to 2014, including income taxes on acquisition-related and exit and realignment charges, is a result of the amount of pretax income earned in different tax jurisdictions and the deductibility of certain acquisition-related charges for income tax purposes.

26


Table of Contents

Financial Condition, Liquidity and Capital Resources
Financial condition. We monitor operating working capital through days sales outstanding (DSO) and merchandise inventory turnover. We estimate a hypothetical increase (decrease) in DSO of one day would result in a decrease (increase) in our cash balances, an increase (decrease) in borrowings against our revolving credit facility, or a combination thereof of approximately $25 million.
The majority of our cash and cash equivalents are held in cash depository accounts with major banks in the United States and Europe or invested in high-quality, short-term liquid investments. Changes in our working capital can vary in the normal course of business based upon the timing of inventory purchases, collection of accounts receivable, and payment to suppliers.
 
June 30, 2015
 
December 31, 2014
 
Change
(Dollars in thousands)
 
 
$
 
%
Cash and cash equivalents
$
200,969

 
$
56,772

 
$
144,197

 
254.0
 %
Accounts and notes receivable, net of allowances
$
580,739

 
$
626,192

 
$
(45,453
)
 
(7.3
)%
Consolidated DSO (1)
20.4

 
22.1

 

 

Merchandise inventories
$
903,501

 
$
872,457

 
$
31,044

 
3.6
 %
Consolidated inventory turnover (2)
9.6

 
10.1

 

 

Accounts payable
$
753,495

 
$
608,846

 
$
144,649

 
23.8
 %
(1) Based on period end accounts receivable and net revenue for the quarter
(2) Based on average annual inventory and annualized cost of goods sold based on the quarter ended June 30, 2015 and December 31, 2014
Liquidity and capital expenditures. The following table summarizes our consolidated statements of cash flows for the six months ended June 30, 2015 and 2014:
(Dollars in thousands)
2015
 
2014
Net cash provided by (used for):
 
 
 
Operating activities
$
246,790

 
$
73,472

Investing activities
(21,988
)
 
(36,841
)
Financing activities
(76,132
)
 
(45,329
)
Effect of exchange rate changes
(4,473
)
 
(1,180
)
Increase (decrease) in cash and cash equivalents
$
144,197

 
$
(9,878
)
Cash provided by operating activities was $246.8 million in the first six months of 2015, compared to $73.5 million in the same period of 2014. The increase in cash from operating activities for the first six months of 2015 compared to the same period in 2014 was primarily due to timing of payments to vendors and improvements in net working capital.
Cash used for investing activities was $22.0 million in the first six months of 2015, compared to $36.8 million in the same period of 2014. Investing activities in 2015 and 2014 related to capital expenditures for our strategic and operational efficiency initiatives, particularly initiatives relating to information technology enhancements and optimizing our distribution network.
Cash used for financing activities in the first six months of 2015 was $76.1 million, compared to $45.3 million used in the same period of 2014. During the first six months of 2015, we paid dividends of $31.9 million (compared to $31.6 million in 2014), repurchased common stock under a share repurchase program for $7.4 million (compared to $9.4 million in 2014) and repaid $33.7 million in borrowings on our Amended Credit Agreement. Financing activities in 2014 also included proceeds of $1.2 million from the exercise of stock options and the cash purchase of the noncontrolling interest in a subsidiary for $1.5 million.
Capital resources. Our sources of liquidity include cash and cash equivalents and a revolving credit facility. On September 17, 2014, we amended our existing Credit Agreement with Wells Fargo Bank, N.A., JPMorgan Chase Bank, N.A., Bank of America, N.A. and a syndicate of financial institutions (the Amended Credit Agreement) increasing our borrowing capacity from $350 million to $450 million and extending the term through 2019. Under the Amended Credit Agreement, we have the ability to request two one-year extensions and to request an increase in aggregate commitments by up to $200 million. The interest rate on the Amended Credit Agreement, which is subject to adjustment quarterly, is based on the London Interbank Offered Rate (LIBOR), the Federal Funds Rate or the Prime Rate, plus an adjustment based on the better of our debt ratings or leverage ratio (Credit Spread) as defined by the Amended Credit Agreement. We are charged a commitment fee of between 12.5 and 25.0 basis points on the unused portion of the facility. The terms of the Amended Credit Agreement limit the amount

27


Table of Contents

of indebtedness that we may incur and require us to maintain ratios for leverage and interest coverage, including on a pro forma basis in the event of an acquisition. We may utilize the revolving credit facility for long-term strategic growth, capital expenditures, working capital and general corporate purposes. If we were unable to access the revolving credit facility, it could impact our ability to fund these needs. Based on our leverage ratio at June 30, 2015, the interest rate under the credit facility is LIBOR plus 1.375%.
At June 30, 2015 , we had no borrowings and letters of credit of approximately $5.0 million outstanding under the Amended Credit Agreement, leaving $445 million available for borrowing. We also have a $1.2 million letter of credit outstanding as of June 30, 2015 and December 31, 2014 which supports our facilities leased in Europe.
On September 16, 2014, we issued $275 million of 3.875% senior notes due 2021 (the “2021 Notes”) and $275 million of 4.375% senior notes due 2024 (the “2024 Notes”). The 2021 Notes were sold at 99.5% of the principal amount with an effective yield of 3.951%. The 2024 Notes were sold at 99.6% of the principal amount with an effective yield of 4.422%. Interest on the 2021 Notes and 2024 Notes is payable semiannually in arrears, commencing on March 15, 2015 and December 15, 2014, respectively. We have the option to redeem the 2021 Notes and 2024 Notes in part or in whole prior to maturity at a redemption price equal to the greater of 100% of the principal amount or the present value of the remaining scheduled payments discounted at the Treasury Rate plus 30 basis points.
In the second quarter of 2015, we paid cash dividends on our outstanding common stock at the rate of $0.2525 per share, which represents a 1.0% increase over the rate of $0.25 per share paid in the second quarter of 2014. We anticipate continuing to pay quarterly cash dividends in the future. However, the payment of future dividends remains within the discretion of the Board of Directors and will depend upon our results of operations, financial condition, capital requirements and other factors.
In February 2014, the Board of Directors authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2017. The program is intended, in part, to offset shares issued in conjunction with our stock incentive plan and return capital to shareholders. The program may be suspended or discontinued at any time. Purchases under the share repurchase program are made either pursuant to 10b5-1 plans entered into by the company from time to time and/or during the company’s scheduled quarterly trading windows for officers and directors. During the first six months of 2015, we repurchased approximately 0.2 million shares for $7.4 million under this program. At June 30, 2015, the remaining amount authorized for repurchase under this program was $82.6 million.
We earn a portion of our operating earnings in foreign jurisdictions outside the U.S., which we consider to be indefinitely reinvested. Accordingly, no U.S. federal and state income taxes and withholding taxes have been provided on these earnings. Our cash, cash-equivalents, short-term investments, and marketable securities held by our foreign subsidiaries totaled $39.7 million and $31.5 million as of June 30, 2015 and December 31, 2014. We do not intend, nor do we foresee a need, to repatriate these funds or other assets held outside the U.S. In the future, should we require more capital to fund discretionary activities in the U.S. than is generated by our domestic operations and is available through our borrowings, we could elect to repatriate cash or other assets from foreign jurisdictions that have previously been considered to be indefinitely reinvested.
We believe available financing sources, including cash generated by operating activities and borrowings under the Amended Credit Agreement, will be sufficient to fund our working capital needs, capital expenditures, long-term strategic growth, payments under long-term debt and lease arrangements, payments of quarterly cash dividends, share repurchases and other cash requirements. While we believe that we will have the ability to meet our financing needs in the foreseeable future, changes in economic conditions may impact (i) the ability of financial institutions to meet their contractual commitments to us, (ii) the ability of our customers and suppliers to meet their obligations to us or (iii) our cost of borrowing.
Recent Accounting Pronouncements
For a discussion of recent accounting pronouncements, see Note 17 in the Notes to Consolidated Financial Statements, included in this Quarterly Report on Form 10-Q for the quarterly period ended on June 30, 2015.
Forward-looking Statements
Certain statements in this discussion constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Although we believe our expectations with respect to the forward-looking statements are based upon reasonable assumptions within the bounds of our knowledge of our business and operations, all forward-looking statements involve risks and uncertainties and, as a result, actual results could differ materially from those projected, anticipated or implied by these statements. Such forward-looking statements involve known and unknown risks, including, but not limited to:
competitive pressures in the marketplace, including intense pricing pressure;

28


Table of Contents

our ability to retain existing and attract new customers in a market characterized by significant customer consolidation and intense cost-containment initiatives;
our dependence on sales to certain customers or the loss or material reduction in purchases by key customers;
our dependence on distribution of product of certain suppliers;
our ability to successfully identify, manage or integrate acquisitions;
our ability to successfully manage our international operations, including risks associated with changes in international trade regulations, foreign currency volatility, changes in regulatory conditions, deteriorating economic conditions, adverse tax consequences, and other risks of operating in international markets;
uncertainties related to and our ability to adapt to changes in government regulations, including healthcare laws and regulations (including the Affordable Care Act);
risks arising from possible violations of legal, regulatory or licensing requirements of the markets in which we operate;
uncertainties related to general economic, regulatory and business conditions;
our ability to successfully implement our strategic initiatives;
the availability of and modifications to existing supplier funding programs and our ability to meet the terms to qualify for certain of these programs;
our ability to adapt to changes in product pricing and other terms of purchase by suppliers of product;
the ability of customers and suppliers to meet financial commitments due to us;
changes in manufacturer preferences between direct sales and wholesale distribution;
changing trends in customer profiles and ordering patterns and our ability to meet customer demand for additional value-added services;
our ability to manage operating expenses and improve operational efficiencies in response to changing customer profiles;
our ability to meet performance targets specified by customer contracts under contractual commitments;
availability of and our ability to access special inventory buying opportunities;
the ability of business partners and financial institutions to perform their contractual responsibilities;
the effect of price volatility in the commodities markets, including fuel price fluctuations, on our operating costs and supplier product prices;
our ability to continue to obtain financing at reasonable rates and to manage financing costs and interest rate risk;
the risk that information systems are interrupted or damaged or fail for any extended period of time, that new information systems are not successfully implemented or integrated, or that there is a data security breach in our information systems;
the risk that a decline in business volume or profitability could result in an impairment of goodwill or other long-lived assets;
our ability to timely or adequately respond to technological advances in the medical supply industry;
the costs associated with and outcome of outstanding and any future litigation, including product and professional liability claims;
adverse changes in U.S. and foreign tax laws and the outcome of outstanding tax contingencies and legislative and tax proposals; and
other factors described in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2014.
We undertake no obligation to update or revise any forward-looking statements, except as required by applicable law.

29


Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to market risk from changes in interest rates related to our revolving credit facility. We had no outstanding borrowings and approximately $5 million in letters of credit under the revolving credit facility at June 30, 2015. A hypothetical increase in interest rates of 100 basis points would result in a potential reduction in future pre-tax earnings of approximately $0.1 million per year for every $10 million of outstanding borrowings under the revolving credit facility.
Due to the nature and pricing of our Domestic segment distribution services, we are exposed to potential volatility in fuel prices. Our strategies for helping to mitigate our exposure to changing domestic fuel prices has included entering into leases for trucks with improved fuel efficiency and entering into fixed–price agreements for diesel fuel. We benchmark our domestic diesel fuel purchase prices against the U.S. Weekly Retail On-Highway Diesel Prices (benchmark) as quoted by the U.S. Energy Information Administration. The benchmark averaged $2.88 per gallon in the first six months of 2015, a decrease from $3.94 per gallon in the first six months of 2014. Based on our fuel consumption in the first six months of 2015, we estimate that every 10 cents per gallon increase in the benchmark would reduce our Domestic segment operating earnings by approximately $0.3 million on an annualized basis.
In the normal course of business, we are exposed to foreign currency translation and transaction risks. Our business transactions outside of the United States are primarily denominated in the Euro and British Pound. We may use foreign currency forwards, swaps and options, where possible, to manage our risk related to certain foreign currency fluctuations. However, we believe that our foreign currency transaction risks are low since our revenues and expenses are typically denominated in the same currency.
Item 4. Controls and Procedures
We carried out an evaluation, with the participation of management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (pursuant to Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based upon that evaluation, the principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of June 30, 2015. There has been no change in our internal control over financial reporting during the quarter ended June 30, 2015, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
SEC guidance permits the exclusion of an evaluation of the effectiveness of a registrant's disclosure controls and procedures as they relate to the internal control over financial reporting for an acquired business during the first year following such acquisition. In the fourth quarter of 2014, we acquired Medical Action and ArcRoyal. These acquisitions represented $323 million of total assets and $95.2 million of net revenues as of and for the six months ended June 30, 2015. Management's evaluation and conclusion as to the effectiveness of the design and operation of the Company's disclosure controls and procedures as of and for the period covered by this report excludes any evaluation of the internal control over financial reporting of these acquisitions.
Part II. Other Information
Item 1. Legal Proceedings
Certain legal proceedings pending against us are described in our Annual Report on Form 10-K for the year ended December 31, 2014. Through June 30, 2015, there have been no material developments in any legal proceedings reported in such Annual Report.
Item 1A. Risk Factors
Certain risk factors that we believe could affect our business and prospects are described in our Annual Report on Form 10-K for the year ended December 31, 2014. Through June 30, 2015, there have been no material changes in the risk factors described in such Annual Report.

30


Table of Contents

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities
In February 2014, our Board of Directors authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2017. The program is intended, in part, to offset shares issued in conjunction with our stock incentive plan and return capital to shareholders. The program may be suspended or discontinued at any time. Purchases under the share repurchase program are made either pursuant to 10b5-1 plans entered into by the company from time to time and/or during the company’s scheduled quarterly trading windows for officers and directors. For the three months ended June 30, 2015, we repurchased in open-market transactions and retired 220 thousand shares of our common stock for an aggregate of $7.4 million, or an average price per share of $33.82. The following table summarizes share repurchase activity by month during the three months ended June 30, 2015.
Period
Total number
of shares purchased
 
Average price paid per share
 
Total number of
shares purchased
as part of a
publicly announced program
 
Maximum dollar
value of shares
that may yet
be purchased under the program
April 2015
10,000

 
$
34.12

 
10,000

 
$
89,658,675

May 2015
100,000

 
$
33.74

 
100,000

 
$
86,282,178

June 2015
110,000

 
$
33.82

 
110,000

 
$
82,560,246

Total
220,000

 
 
 
220,000

 
 

31


Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
Owens & Minor, Inc.
 
 
 
(Registrant)
 
 
 
 
Date:
July 28, 2015
 
/s/ P. Cody Phipps
 
 
 
P. Cody Phipps
 
 
 
President & Chief Executive Officer
 
 
 
 
Date:
July 28, 2015
 
/s/ Richard A. Meier
 
 
 
Richard A. Meier
 
 
 
Executive Vice President & Chief Financial Officer
 

32


Table of Contents

Item 6. Exhibits
 
(a)
Exhibits
10.1
 
Agreement dated February 14, 2015 Regarding Retirement of James L. Bierman

 
 
 
10.2
 
Employment Term Sheet effective May 20, 2015 for P. Cody Phipps
 
 
 
10.3
 
Restricted Stock Grant Agreement dated July 1, 2015 between the Company and P. Cody Phipps
 
 
 
10.4
 
Owens & Minor, Inc. Officer Severance Policy
 
 
 
10.5
 
Amended Form of Annual Executive Incentive Program
 
 
 
10.6
 
Form of Director Restricted Stock Grant Agreement under Owens & Minor, Inc. 2015 Stock Incentive Plan
 
 
 
10.7
 
Form of Officer Restricted Stock Grant Agreement under Owens & Minor, Inc. 2015 Stock Incentive Plan
 
 
 
10.8
 
Form of Performance Share Award Agreement under Owens & Minor, Inc. 2015 Stock Incentive Plan
 
 
 
31.1
  
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
31.2
  
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
32.1
  
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
32.2
  
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
101.INS
  
XBRL Instance Document
 
 
 
101.SCH
  
XBRL Taxonomy Extension Schema Document
 
 
 
101.CAL
  
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
101.DEF
  
XBRL Taxonomy Definition Linkbase Document
 
 
 
101.LAB
  
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
101.PRE
  
XBRL Taxonomy Extension Presentation Linkbase Document

33